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Abstract
Background: There is a need for brief instruments to ascertain the diagnosis of major depressive disorder. In this
study, we present the reliability, construct validity and accuracy of the PHQ-9 and PHQ-2 to detect major
depressive disorder in primary care.
Methods: Cross-sectional analyses within a large prospective cohort study (PREDICT-NL). Data was collected in
seven large general practices in the centre of the Netherlands. 1338 subjects were recruited in the general practice
waiting room, irrespective of their presenting complaint. The diagnostic accuracy (the area under the ROC curve
and sensitivities and specificities for various thresholds) was calculated against a diagnosis of major depressive
disorder determined with the Composite International Diagnostic Interview (CIDI).
Results: The PHQ-9 showed a high degree of internal consistency (ICC = 0.88) and test-retest reliability (correlation
= 0.94). With respect to construct validity, it showed a clear association with functional status measurements, sick
days and number of consultations. The discriminative ability was good for the PHQ-9 (area under the ROC curve =
0.87, 95% CI: 0.84-0.90) and the PHQ-2 (ROC area = 0.83, 95% CI 0.80-0.87). Sensitivities at the recommended
thresholds were 0.49 for the PHQ-9 at a score of 10 and 0.28 for a categorical algorithm. Adjustment of the
threshold and the algorithm improved sensitivities to 0.82 and 0.84 respectively but the specificity decreased from
0.95 to 0.82 (threshold) and from 0.98 to 0.81 (algorithm). Similar results were found for the PHQ-2: the
recommended threshold of 3 had a sensitivity of 0.42 and lowering the threshold resulted in an improved
sensitivity of 0.81.
Conclusion: The PHQ-9 and the PHQ-2 are useful instruments to detect major depressive disorder in primary care,
provided a high score is followed by an additional diagnostic work-up. However, often recommended thresholds
for the PHQ-9 and the PHQ-2 resulted in many undetected major depressive disorders.
Background
Assessment of major depressive disorder with (semi-)
structured interviews such as the CIDI or the SCID
[1,2], can be time consuming in the primary care setting.
There is a need for using brief instruments such as the
Patient Health Questionnaire-9 (PHQ-9) and the
PHQ-2 [3], to ascertain the diagnosis of major depres-
sive disorder.
The PHQ-9 is derived from PRIME-MD[4] which was
originally developed to detect five common mental dis-
orders in primary care: depression, anxiety, alcohol
abuse, somatoform disorder, and eating disorder. It is a
self-report questionnaire that assesses the levels of
depression on the nine key symptoms (each rated from
0-3) in the past two weeks. The scores on the question-
naire range from 0 to 27: a score of 10 or higher is
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to consider major depressive disorder present[3,5-8].
The score can also be used as a measure of depression
severity[3,9]. A categorical algorithm has also been
developed to determine major depressive disorder with
the PHQ-9[3,9]. The PHQ-2 includes the first two items
of the PHQ-9, ‘any depressed feelings’ and ‘any loss of
interest’[10] and ranges from 0 to 6. In order to detect
major depressive disorder with the PHQ-2, a threshold
of 3 is recommended.
Several studies validated the performance of both
questionnaires in a variety of patient populations, most
of them showing good accuracy[3,5-8,11-16]. However,
the PHQ-9 has not yet been validated in primary care
in the Netherlands. Furthermore, very few studies vali-
dated the accuracy of the PHQ-2[10,12,16,17].
We validated both the PHQ-9 and the PHQ-2 in a
large Dutch primary care patient cohort addressing
t h r e eq u e s t i o n s :( 1 )I st h eP H Q - 9ar e l i a b l ea n dv a l i d
measurement of major depressive disorder in primary
care? Reliability refers to internal consistency as well as
test-retest reliability. Validity refers to construct validity,
i.e. is the PHQ-9 an adequate measurement of depres-
sion severity; 2) Does the threshold score of 10 and the
categorical algorithm for the PHQ-9 yield accurate clas-
sification in primary care?; (3) What is the accuracy of
the PHQ-2 for major depressive disorder in primary
care?
Methods
Patients and design
We used patient data of the PREDICT-NL study, which
is the Dutch part of the PredictD study. The design and
primary results of the PredictD study have been pub-
lished previously[18,19]. In brief, PredictD is a large pro-
spective cohort study that started in 2003 from which a
multifactor risk algorithm was developed for the onset
of major depression over 12 months in primary care in
6 European countries and Chile[18]. Consecutive general
practice patients were asked to participate, irrespective
of their reasons for consulting the general practitioner.
The study was approved by the Medical Ethics commit-
tee of the universities of participating countries.
In the Netherlands, patients were recruited from seven
general practices in the city of Utrecht and surrounding
areas. On random days, research assistants visited the
general practices to recruit patients. Patients aged 18
years or older who visited the general practice were
asked to participate while waiting to see the general
practitioner. Patients interested in participating were
given oral and written information about the study aims
and procedure. If patients were willing to participate,
they received the study information sheet, an informed
consent form, and the questionnaires. The patient was
asked to take the material home, read the study infor-
mation and ask for additional information if necessary.
After having signed the informed consent form they
filled out the questionnaire and returned the signed
informed consent form and questionnaire by regular
mail. Nonresponders were sent a reminder after two
weeks and again after four weeks.
To assess the test-retest reliability of the PHQ-9,
thirty-two consecutively included study participants in
one general practice were asked to fill out the PHQ
questionnaire for a second time after 14 days.
Diagnosis of major depressive disorder (reference
standard)
The diagnosis of major depressive disorder was assessed
in all patients according to DSM-IV criteria[20] by
trained researchers using the depression section of the
Composite International Diagnostic Interview (CIDI)
[21]. When informed consent and the questionnaire
were received, the researchers phoned the participant
and asked the two core questions of the depression sec-
tion of the CIDI interview[21], i.e. did you have a
depressed mood or a loss of interest for a 2-week-period
or longer in the past six months. If the participant
responded negative to both questions a diagnosis of
major depressive disorder was ruled out[20,21]. If the
participant responded positive on one or both questions,
an appointment was made in the general practice to
conduct the full CIDI depression interview to establish
the presence of major depressive disorder. If the partici-
pant was unable to schedule the interview at the general
practice, the interview was done by telephone (26% of
the interviews). The electronic processing of the ques-
tionnaires was done completely separate from the CIDI
interview, thus effectively blinding the researchers from
the PHQ-9 answers.
Patient health questionnaire
E a c ho ft h en i n eq u e s t i o n so ft h eP H Q - 9w a se v a l u a t e d
on a 4-point rating scale, ranging from 0 (not at all) to
3 (nearly every day), summing up to a total PHQ-9
score per patient. Major depressive disorder was consid-
ered present if the score was >= 10[3,5-8]. For the cate-
gorical algorithm, the answers on the questions were
dichotomized: 0 (not at all) and 1 (several days) are
coded as 0 (symptom absent) and the answers 2 (more
than half the days) and 3 (nearly every day) are coded as
1 (symptom present). The diagnosis of major depressive
disorder is made when at least five symptoms are pre-
sent, and at least one is ‘depressed feelings’ or ‘loss of
interest’[3,20]. For the PREDICT-NL study, the Dutch
version of the PHQ-9 was developed using several steps
of translating and back-translating by researchers and
professional translators, one of whom was a native
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PHQ-9: only the core symptoms of major depressive
disorder (’depressed feelings’ and ‘loss of interest’), the
first two items, are measured as described above, sum-
ming up to a total that ranges from 0 to 6.
Functional status, sick days, and number of consultations
We also assessed other parameters to evaluate the valid-
ity of the PHQ-9. These were:
1) Functional status using the Medical Outcome Study
Short Form General Health Questionnaire-12 (SF-12)
[22]. This instrument is divided into scales for mental
and physical health, where higher scores indicate better
functioning.
2) Information on the number of days in the past
4 weeks that patients were unable to perform usual
activities due to health problems (number of sick days).
3) The number of general practice consultations in the
past 12 months was counted using the electronic data-
base of the general practitioners. This was assessed as a
measure of health service utilisation.
Data analysis
We estimated the internal consistency, the degree to
which the answers on the individual questions of the
PHQ-9 are the same, using intraclass correlations and
the test-retest correlation were estimated using Pearson
correlations. To assess the validity of the PHQ-9 as a
measurement of depression severity, scores were divided
i nc a t e g o r i e so fi n c r e a s i n gs e v e r i t y :0 - 4 ,5 - 9 ,1 0 - 1 4 ,
15-19 and 20 and higher, as used in other studies[3].
Medians and interquartile ranges of the functional status
(SF-12), sick days and the number of consultations in
the previous 12 months were estimated across these
categories. Differences between categories were tested
with Kruskal-Wallis analysis of variance. Differences in
PHQ-9 and PHQ-2 scores between patients with and
without major depressive disorder were tested with the
Mann-Whitney U test. P-values of 0.05 and lower were
considered significant.
We then estimated the concordance-statistic (c-statis-
tic or area under the Receiver Operating Characteristic
curve) for the PHQ-9. The sensitivity, specificity, and
positive and negative predictive value were estimated for
several thresholds of the PHQ-9 overall score and for
the categorical algorithm of the PHQ-9. Finally, the
c-statistic was constructed for the PHQ-2 and sensitiv-
ity, specificity, positive and negative predictive value
were calculated for all possible thresholds of the PHQ-2.
The overall percentage of missing values was 9%. As
missing data rarely occur at random, it is widely
acknowledged that simple deletion of patients with one
or more missing values (i.e. complete case analysis)
leads to biased results[23-26]. We therefore used single
imputation to address missing values. The imputation
and analysis was done in SPSS version 15 (SPSS inc.
Chicago, Ill).
Results
In total, 3089 patients were asked to take part in the
PREDICT-NL study, 83 of whom did not meet inclusion
criteria, mainly (n = 75) because they had problems
understanding the Dutch language. An additional 8
patients were excluded because the general practitioner
confirmed that they had dementia (n = 5), psychosis
(n = 2), or mental retardation (n = 1). Of the 3006 eligi-
ble patients, 1338 (44.5%) gave written informed consent
and participated in the study (Figure 1). Reasons for not
participating were mostly lack of time and no interest in
the study.
T h em e a na g eo ft h es t u d yp o p u l a t i o nw a s5 1y e a r s
(SD = 16.7), and the majority (63%) was female (Table
1). Thirty five patients (2.6%) consulted the general
practitioner for mood related health problems. DSM IV
Major depressive disorder according to the CIDI was
diagnosed in 176 (13%) patients and was more prevalent
in women and younger patients (Table 1). Patients with
major depressive disorder had significantly higher scores
on the PHQ-9 (p < .000) and PHQ-2 (p < .000) com-
pared with patients without depression.
Thirty-one of the 32 patients approached agreed to fill
in the PHQ-9 for a second time. The association
between the test and retest scores was excellent, with a
correlation of 0.94. The internal consistency of the
PHQ-9 was very good with an intraclass correlation of
0.88.
In table 2 the medians of the SF12, the number of sick
days and the number of consultations are shown for
patients in different PHQ-9 categories. A statistically
significant difference in quality of life was observed for
patients with different levels of depressive symptoms,
with patients with higher levels of depression reporting
a lower quality of life. This difference was more pro-
nounced on the mental functioning than the physical
functional scale. A statistical significant difference was
also observed on the reported number of sick days in
the past 4 weeks and number of consultations in the
past twelve months (all p-values < 0.001).
The area under the ROC curve of the PHQ-9 was 0.87
(95% CI: 0.84-0.90). Table 3 shows the accuracy mea-
sures for different thresholds of the PHQ-9 score. The
commonly used threshold of 10 had a specificity of 0.95
but a sensitivity of only 0.49. At a threshold of 6, sensi-
tivity was 0.82 and specificity was 0.82. At this threshold
the a-priori probability (prevalence) of 13% was
increased to a posterior probability of 41%.
The categorical algorithm of the PHQ-9 showed a
specificity of 0.98 and sensitivity of only 0.28. Based on
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include the responses ‘several days’ as symptom present
(see methods), whereas the original algorithm codes
these answers as symptom absent. This resulted in a
sensitivity of 0.84 and specificity of 0.81, close to those
found for a threshold of 6 (Table 3). As the time delay
between the PHQ-9 and the reference test varied, we
performed an additional analysis to determine the influ-
ence of this time delay. Discrimination (area under the
ROC curve) was similar when the delay between PHQ-9
and CIDI was longer (results not shown).
The area under the ROC curve of the PHQ-2 was 0.83
(95% CI 0.80-0.87). The commonly used threshold for
the PHQ-2 of 3 showed a specificity of 0.94 and sensi-
tivity of 0.42 (Table 3). As with the PHQ-9, lower
thresholds showed more balanced values of sensitivity
and specificity, notably at a threshold of 2. At this
threshold, the a-priori probability (prevalence) of 13%
was increased to a posterior probability of 34%.
Discussion
The PHQ-9 showed a very good internal consistency
and test-retest reliability. Moreover, more severe depres-
sive symptoms as measured by the PHQ were associated
with poorer functional status, sick days, and higher
number of general practice consultations. The accuracy
of detecting major depressive disorder at the recom-
mended threshold of 10 and for the categorical algo-
rithm, however, was poor. Lowering the threshold and
minor adjustments of the categorical algorithm showed
a considerable improvement of sensitivity, at the cost of
lower specificity (Table 3). The adjusted categorical
1751 excluded:
Understanding Dutch language (N=75)
Dementia (N=5)
Psychosis (N=2)
Mental retardation (N=1)
Refused (N=1668)
1338 participants
3089 eligible patients
Figure 1 Flow chart of the inclusion of patients.
Table 1 Distribution of patient characteristics according to diagnostic status for major depressive disorder
Major depressive disorder Total
No
(N = 1176)
Yes
(N = 176)
Male gender, n (%) 448 (39) 50(28) 498 (37)
Age (years), mean(SD) 52 (17) 46(14) 51 (17)
PHQ-9, median(IQR
1) 2 (1-5) 9 (6-14) 3 (1-6)
PHQ-2, median(IQR) 0 (0-1) 2 (2-4) 0 (0-2)
Physical functioning, SF-12, median(IQR) 50 (40-54) 48 (40-57) 49 (40-54)
Mental functioning, SF-12, median(IQR) 52 (45-56) 30 (25-38) 50 (41-56)
Sick days (n), median(IQR) 0 (0-5) 3 (0-10) 0 (0-5)
Consultations in previous 12 months(n), median(IQR) 9 (5-16) 12 (7-20) 10 (5-16)
1 IQR - interquartile ranges
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as item present. The PHQ-2 showed a similar level of
accuracy (i.e. sensitivity and specificity) when a lower
threshold of 2 rather than 3 was used.
Our results of the reliability and construct validity of
the PHQ-9 are similar to those reported in another pri-
mary care study[3] and a study of chronically ill primary
care patients[13]. When we compared our observed sen-
sitivities and specificities with other studies, we noted
mixed results in the existing literature. A systematic
review of the PHQ-9 in primary care found a pooled
sensitivity of 0.77 (95% CI: 0.71-0.84) and a pooled spe-
cificity of 0.94 (95% CI: 0.90-0.97) for the diagnostic
algorithm [15]. Similar results were found for
the threshold of 10 in a systematic review by Gilbody et.
al. [12]. Both reviews report substantially higher
sensitivities compared to those reported here. However,
a number of other studies in specific patients popula-
tions (e.g. patients with cardiovascular diseases) also
observed low sensitivities and comparable specificities as
we observed[13,17,27]. Similarly, the recommended
threshold of 3 for the PHQ-2 showed a low sensitivity
in comparison with other primary care studies[7,10,28],
whereas other studies describe results similar to those
reported here[16,17,29].
Strengths of this study are, first, that patients were
included consecutively on random days, irrespective of
their presented symptoms or signs and thus represent-
ing all patients in the waiting room of the GP. Second,
patients were approached for participation in several
general practices in both rural and urban areas to
ensure a representative sample. Third, the reference test
Table 2 Association between PHQ-9 depression score and SF-12 health related quality of life scores, sick days and
number of consultations in the past 12 months
Level of depression severity (PHQ-9 score)
Minimal
(0-4)
Mild
(5-9)
Moderate
(10-14)
Moderately severe
(15-19)
Severe
(20-27)
p-value
2
Physical functioning, Median (IQR
1) 50 (42-54) 47 (38-54) 47 (38-57) 41 (34-52) 42 (39-50) 0.00
Mental functioning, Median (IQR) 54 (49-57) 42 (33-49) 30 (25-36) 26 (21-34) 21 (17-28) 0.00
Sick days, median (IQR) 0 (0-4) 1 (0-7) 6 (0-15) 7 (2-20) 8 (1-15) 0.00
Consultations in previous 12 months, Median (IQR) 9 (5-15) 11 (6-17) 14 (8-22) 16 (7-27) 12 (9-25) 0.00
1IQR - Interquartile range
2 P-values from Kruskal-Wallis tests
Table 3 Sensitivity, specificity, and predictive values for different thresholds of the PHQ-9 and the PHQ-2
PHQ-9 threshold Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
≥4 0.89 (0.84-0.94) 0.64 (0.61-0.67) 0.27 (0.23-0.31) 0.97 (0.96-0.98)
≥5 0.86 (0.81-0.91) 0.75 (0.73-0.77) 0.34 (0.30-0.38) 0.97 (0.96-0.98)
≥6 0.82 (0.76-0.88) 0.82 (0.80-0.84) 0.41 (0.36-0.46) 0.97 (0.96-0.98)
≥7 0.74 (0.68-0.80) 0.87 (0.85-0.89) 0.47 (0.41-0.53) 0.96 (0.95-0.97)
≥8 0.65 (0.58-0.72) 0.90 (0.88-0.92) 0.51 (0.44-0.58) 0.94 (0.93-0.95)
≥9 0.57 (0.50-0.64) 0.93 (0.92-0.94) 0.55 (0.48-0.62) 0.94 (0.93-0.95)
≥10 0.49 (0.42-0.56) 0.95 (0.94-0.96) 0.59 (0.51-0.67) 0.93 (0.92-0.94)
≥11 0.44 (0.37-0.51) 0.96 (0.95-0.97) 0.61 (0.53-0.61) 0.92 (0.90-0.94)
≥12 0.39 (0.32-0.46) 0.97 (0.96-0.98) 0.64 (0.55-0.74) 0.92 (0.89-0.93)
PHQ-9 algorithm 0.28 (0.21-0.35) 0.98 (0.97-0.99) 0.69 (0.58-0.80) 0.90 (0.88-0.92)
PHQ-9 adjusted algorithm 0.84 (0.79-0.89) 0.81 (0.79-0.83) 0.40 (0.35-0.45) 0.97 (0.96-0.98)
PHQ-2 threshold
≥1 0.90 (0.86-0.94) 0.58 (0.55-0.61) 0.24 (0.21-0.27) 0.98 (0.97-0.99)
≥2 0.81 (0.75-0.84) 0.76 (0.74-0.78) 0.34 (0.29-0.39) 0.96 (0.95-0.97)
≥3 0.42 (0.35-0.49) 0.94 (0.93-0.95) 0.53 (0.45-0.61) 0.91 (0.89-0.93)
≥4 0.31 (0.24-0.38) 0.97 (0.96-0.98) 0.64 (0.54-0.74) 0.90 (0.88-0.92)
≥5 0.19 (0.13-0.25) 0.99 (0.98-1.00) 0.69 (0.56-0.82) 0.89 (0.87-0.91)
≥6 0.14 (0.09-0.19) 0.99 (0.98-1.00) 0.67 (0.52-0.82) 0.88 (0.86-0.90)
For details see text.
PPV: Positive predictive value
NPV: Negative predictive value
95% CI: 95% Confidence Interval
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guarantee the validity of the diagnoses and was applied
in all attendees so that there was no selection bias.
Fourth, this is the first study that validates the PHQ-9
and PHQ-2 in Dutch primary care.
Our study also has some limitations. First, the non-
response rate for this study was relatively high. How-
ever, we found very minor non-significant differences in
distributions of gender and age compared to responders
(data not shown). Second, the prevalence of major
depressive disorder in this study was relatively high
[30-32]. It is possible that patients with major depressive
disorder or similar mood problems were more willing to
participate in our study. As a result, we would expect
sensitivities and positive predicted values to be overesti-
mated and specificities and negative predictive values to
be underestimated[33]. This, however, is not consistent
with the results presented here and therefore unlikely to
explain our findings. Third, the test-retest reliability was
assessed in only 31 patients. Still, the results were very
similar to earlier findings[3,13]. Fourth, the question-
naire was filled out at home. It is therefore possible that
the answers were influenced by others (e.g. family mem-
bers). However, this influence had to be systematically
in one direction for patients with major depressive dis-
o r d e ra n dm o r eo rl e s sa b s e n tf o ra l lo t h e rp a t i e n t st o
explain our findings, which is unlikely. Furthermore,
t h e r ew a sat i m ed e l a yb e t w e e nt h eP H Q - 9a n dt h e
CIDI. However, in an additional analysis, we observed
no influence of the time delay on sensitivities and speci-
ficities of the PHQ-9. Also, a substantial part of the
CIDI interviews was administered by telephone. Pre-
vious studies, however, have shown that telephone inter-
views are valid for clinical assessment of depression
[31,34]. It has been suggested that the CIDI underde-
tects major depressive disorder when compared to the
SCID [31]. In larger clinical or epidemiological studies,
however, it is not feasible to administer the SCID in all
patients because this is a semi-structured interview that
has to be administered by clinicians instead of trained
lay-persons. Also, most critical evaluations of the CIDI
were based on earlier versions than the version (2.1)
used in our study[35].
The limitations of our study cannot, in our view,
explain the low sensitivities for detecting major depres-
sive disorder we observed. Differences between the
PHQ-9 and reference tests such as the CIDI and the
SCID, have been previously described[15]. The PHQ-9
is designed to inquire about symptoms of major depres-
sive disorder in the past 2 weeks rather than the past 12
months (adapted to the past 6 months in our study) for
the CIDI. Patients with symptoms of major depressive
disorder in the past 6 months and less severe symptoms
in the past 2 weeks will not be detected with the PHQ-9
or the PHQ-2. Conversely, patients reporting little or no
symptoms in the CIDI interview will also report no
symptoms on the PHQ-9. As such, this difference in
time frame could very easily result in low sensitivities
and high specificities for the PHQ-9 threshold and algo-
rithm and the recommended threshold for the PHQ-2.
The currently recommended high thresholds will lead
to large numbers of undetected depressions. Before
applied in clinical practice, lower threshold values as
considered in the present study should be evaluated in
other studies with new patients and different settings.
The high negative predictive value and a relative low
positive predictive value at the lower threshold of 6
(Table 3) showed that exclusion of major depressive dis-
order is more feasible than inclusion. Even though the
positive predicted value of 41% still represents a consid-
erable increase of the a-priori probability of 13%, it also
emphasizes the need for a further diagnostic work-up
for major depressive disorder in patients with a high
score on the PHQ-9.
Conclusion
In conclusion, the results presented here indicate that
the PHQ-9 and the PHQ-2 are useful instruments to
detect major depressive disorder in primary care. As the
positive predictive value is still low, a high score needs
to be followed by an additional diagnostic work-up. In
addition, the PHQ-9 is a valid measurement of depres-
sion severity. For both scales, however, clinicians should
be aware that current recommended thresholds could
lead to under detection.
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